NABRIVA THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NBRVF and buy or sell other stocks, ETFs, and their options commission-free!About NBRVF
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
CEOH. Michael Hogan
CEOH. Michael Hogan
Employees39
Employees39
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees39
Employees39
NBRVF Key Statistics
Market cap323.08
Market cap323.08
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume204.80
Average volume204.80
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.01
52 Week high$0.01
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
NABRIVA THERAPEUTICS(NBRVF) stock is priced at $0.00, giving the company a market capitalization of 323.08.
On 2025-12-17, NABRIVA THERAPEUTICS(NBRVF) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 204.8.
The stock's 52-week range extends from a low of $0.00 to a high of $0.01.
The stock's 52-week range extends from a low of $0.00 to a high of $0.01.
People also own
Based on the portfolios of people who own NBRVF. This list is generated using Robinhood data, and it’s not a recommendation.